Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02253532PMID 7870984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

  2005cited by this paper
• MK-801-induced stereotypy and its antagonism by neuroleptic drugs

  2005cited by this paper
• The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

  2005cited by this paper
• Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat

  2005cited by this paper
• Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice

  2005cited by this paper
• A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats

  2004cited by this paper
• Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens

  2004cited by this paper
• Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat

  2004cited by this paper
• Intrastriatal injection of dl-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine

  2004cited by this paper
• Cellular interactions in the striatum involving neuronal systems using “classical” neurotransmitters: Possible functional implications

  1992cited by this paper
• Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum.

  1992cited by this paper
• A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques.

  1992cited by this paper
• Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study.

  1992cited by this paper
• Mesocorticolimbic dopaminergic network: functional and regulatory roles.

  1991cited by this paper
• Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice.

  1991cited by this paper
• The effects of the noncompetitive NMDA receptor antagonist MK 801 on DRL performance in rats

  1991cited by this paper
• The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats.

  1991cited by this paper
• Do endogenous excitatory amino acids influence striatal dopamine release?

  1991cited by this paper
• NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

  1990cited by this paper
• Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

  1990cited by this paper
• The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

  1989cited by this paper
• In vivo demonstration of the enhancement of MK-801 by L-glutamate.

  1989cited by this paper
• Cellular interactions.

  1988cited by this paper
• Behavioural effects of N-methyl-D-aspartate in the anterodorsal striatum of the rat.

  1988cited by this paper
• MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

  1988cited by this paper
• [3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes

  1988cited by this paper
• A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.

  1987cited by this paper
• Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.

  1986cited by this paper
• Electrophysiological study of the effects of D1 and D2 dopamine antagonists on the interaction of converging inputs from the sensory-motor cortex and substantia nigra neurons in the rat.

  1986cited by this paper
• Glutamate: A Neurotransmitter in Mammalian Brain

  1984cited by this paper
• Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat

  1984cited by this paper
• Presynaptic dopaminergic control of high affinity glutamate uptake in the striatum.

  1983cited by this paper
• Effects of dopamine on spontaneous and evoked activity of caudate neurons.

  1983cited by this paper
• Cortical modulation of striatal function.

  1982cited by this paper
• Anticonvulsant activity of (+)‐5‐methyl‐10, 11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties

  1982cited by this paper
• A simple model for studying benzodiazepines: Potentiation of hyperactivity induced by cocaine in mice

  1982cited by this paper
• Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats.

  1979cited by this paper
• Stereotypic and anticataleptic activities of amphetamine after intracerebral injections.

  1972cited by this paper
• INCREASED SPONTANEOUS ACTIVITY AND FOOD INTAKE PRODUCED IN RATS BY REMOVAL OF THE FRONTAL POLES OF THE BRAIN

  1939cited by this paper
• Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties

  year unknowncited by this paper

• PHARMACOLOGICAL ACTIVITY OF A NEW LIGAND BINDING AT THE HISTAMINE SITE OF THE NMDA RECEPTOR IN RODENTS.

  2026cites this paper
• What value do NMDA receptor antagonist models of schizophrenia have for novel drug discovery?

  2025cites this paper
• Leveraging TRPV1 for intracellular delivery of membrane impermeant compounds in the brain

  2025cites this paper
• Prenatal ketamine exposure impairs prepulse inhibition via arginine vasopressin receptor 1A-mediated GABAergic neuronal dysfunction in the striatum.

  2023cites this paper
• MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems

  2020cites this paper
• Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice

  2020cites this paper
• Behavioural effects of inhalation exposure to dizocilpine (MK-801) in mice.

  2019cites this paper
• Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum

  2018influential citation
• Dizocilpine (MK-801) impairs learning in the active place avoidance task but has no effect on the performance during task/context alternation.

  2016cites this paper
• Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test.

  2015cites this paper
• GABAA overactivation potentiates the effects of NMDA blockade during the brain growth spurt in eliciting locomotor hyperactivity in juvenile mice.

  2015cites this paper
• Nandrolone-induced aggressive behavior is associated with alterations in extracellular glutamate homeostasis in mice.

  2014cites this paper
• Atypical antipsychotic clozapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of DOI into the inferior colliculus in rats

  2013cites this paper
• Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation.

  2013cites this paper
• Atypical antipsychotic olanzapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of dizocilpine (MK-801) into the inferior colliculus in rats.

  2013cites this paper
• Blocking alpha2A adrenoceptors, but not dopamine receptors, augments bupropion‐induced hypophagia in rats

  2013cites this paper
• Dopaminergic system in CA1 modulates MK-801 induced anxiolytic-like responses.

  2012cites this paper
• Effects of Dissociative Exposure in Adolescence on Behavior in Adulthood

  2012cites this paper
• Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats

  2012cites this paper
• Exposure to novel environment is characterized by an interaction of D1/NMDA receptors underlined by phosphorylation of the NMDA and AMPA receptor subunits and activation of ERK1/2 signaling, leading to epigenetic changes and gene expression in rat hippocampus.

  2012cites this paper
• The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations

  2012cites this paper
• Dopamine–Glutamate Interplay in the Ventral Striatum Modulates Spatial Learning in a Receptor Subtype-Dependent Manner

  2012cites this paper
• Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia.

  2011cites this paper
• Gestational MAM (Methylazoxymethanol) Administration: A Promising Animal Model for Psychosis Onset

  2011cites this paper
• SP-8203 shows neuroprotective effects and improves cognitive impairment in ischemic brain injury through NMDA receptor.

  2011cites this paper
• The effect of MK-801 on motor activity and c-Fos protein expression in the brain of adolescent Wistar rats.

  2010cites this paper
• The effect of dopamine receptor blockade in the rodent nucleus accumbens on local field potential oscillations and motor activity in response to ketamine.

  2010cites this paper
• Effect of testing conditions on the propsychotic action of MK-801 on prepulse inhibition, social behaviour and locomotor activity.

  2010cites this paper
• Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics

  2010cites this paper
• Acute neurobehavioral effects of toluene: involvement of dopamine and NMDA receptors.

  2009cites this paper
• The hyperactive syndrome: metanalysis of genetic alterations, pharmacological treatments and brain lesions which increase locomotor activity.

  2008cites this paper
• Morphine-Induced Behavioral Sensitization Increased the mRNA Expression of NMDA Receptor Subunits in the Rat Amygdala

  2008cites this paper
• Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17

  2007cites this paper
• Spontaneous alternation behaviour in rats: kynurenic acid attenuated deficits induced by MK-801.

  2006cites this paper
• 6-Hydroxydopamine lesion of locus coeruleus and the antiparkinsonian potential of NMDA-receptor antagonists in rats

  2005cites this paper
• Interactions between dopamine and GABA in the control of ambulatory activity

  2005cites this paper
• Differential effects of 7-OH-DPAT and apomorphine on hyperactivity induced by MK-801 (dizocilpine) in rats.

  2005cites this paper
• Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats

  2005cites this paper
• MK-801 alters RGS2 levels and adenylyl cyclase sensitivity in the rat striatum

  2005cites this paper
• Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats.

  2005cites this paper
• Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats

  2005cites this paper
• Modulation of the locomotor responses induced by D1-like and D2-like dopamine receptor agonists and D-amphetamine by NMDA and non-NMDA glutamate receptor agonists and antagonists in the core of the rat nucleus accumbens.

  2004cites this paper
• Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.

  2004cites this paper
• Selective blockade of spontaneous motor stereotypy via intrastriatal pharmacological manipulation.

  2003cites this paper
• Motor effects of amphetamine in rats pretreated with either dizocilpine or phencyclidine.

  2003cites this paper
• Age-related differences in MK-801- and amphetamine-induced locomotor and stereotypic activities of rats.

  2003cites this paper
• (-)-Linalool produces antinociception in two experimental models of pain.

  2003cites this paper
• Functional alteration by NMDA antagonist: Effects of L-Dopa, neuroleptics drug and postnatal administration

  2002cites this paper
• The activation of serotonin receptors prevents glutamate-induced neurotoxicity and NMDA-stimulated cGMP accumulation in primary cortical cell cultures.

  2002cites this paper
• Cellular and molecular pathways of ischemic neuronal death.

  2002cites this paper
• D1 and D2 dopamine receptors contribute to the locomotor response induced by Group II mGluRs activation in the rat nucleus accumbens.

  2002cites this paper
• Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms.

  2002cites this paper
• Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.

  2001cites this paper
• Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.

  2001cites this paper
• Pharmacology and behavioral pharmacology of the mesocortical dopamine system.

  2001cites this paper
• The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after infusion of N-methyl-D-aspartate or its noncompetitive antagonist MK-801 into the ventral hippocampus.

  2001cites this paper
• Role of dopaminergic system in core part of nucleus accumbens in hyperlocomotion and rearing induced by MK-801 in rats: a behavioral and in vivo microdialysis study.

  2001cites this paper
• d -Cycloserine, a positive modulator of NMDA receptors, inhibits serotonergic function

  2000cites this paper
• Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agents.

  2000cites this paper
• Effect of chronic food restriction on Fos-like immunoreactivity (FLI) induced in rat brain regions by intraventricular MK-801.

  2000cites this paper
• Chronic food restriction in rats augments the central rewarding effect of cocaine and the delta1 opioid agonist, DPDPE, but not the delta2 agonist, deltorphin-II.

  2000cites this paper
• Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

  2000cites this paper
• Activation of striatal group II metabotropic glutamate receptors has a differential effect on dopamine-D1 and -D2 receptor antagonist-induced hypokinesia in the rat

  2000cites this paper
• Blockade of the serotonergic system counteracts the dizocilpine‐induced changes in dopaminergic function

  2000cites this paper
• Microinfusion of the non-competitive N-methyl-D-aspartate receptor antagonist MK-801 (dizocilpine) into the dorsal hippocampus of wistar rats does not affect latent inhibition and prepulse inhibition, but increases startle reaction and locomotor activity.

  2000cites this paper
• An integrated view of pathophysiological models of schizophrenia.

  1999cites this paper
• Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

  1999cites this paper
• NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.

  1999cites this paper
• Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice

  1999cites this paper
• Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.

  1999cites this paper
• The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function.

  1999cites this paper
• Effects of chronic lead (Pb) exposure on neurobehavioral function and dopaminergic neurotransmitter receptors in rats.

  1999cites this paper
• Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5‐HT2A sites for PCP‐induced locomotion in the rat

  1999cites this paper
• Multiple Limbic Regions Mediate the Disruption of Prepulse Inhibition Produced in Rats by the Noncompetitive NMDA Antagonist Dizocilpine

  1998cites this paper
• Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats.

  1998cites this paper
• Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test

  1998cites this paper
• N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes

  1998cites this paper
• Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.

  1998cites this paper
• MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.

  1997cites this paper
• Olfactory conditioning impairment following posttraining NMDA receptor blockade in neonatal rats.

  1997cites this paper
• A role for D2, but not D1, dopamine receptors in the response-reinstating effects of food reinforcement.

  1997cites this paper
• Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.

  1997cites this paper
• The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats.

  1997cites this paper
• Adenosine A1 and A2 receptor agonists significantly prevent the electroencephalographic effects induced by MK-801 in rats.

  1997cites this paper
• Glutamate in schizophrenia: clinical and research implications.

  1997cites this paper
• Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.

  1997cites this paper
• Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats.

  1997cites this paper
• Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.

  1997cites this paper
• Continuous co‐administration of dextromethorphan or MK‐801 with morphine: attenuation of morphine dependence and naloxone‐reversible attenuation of morphine tolerance

  1996cites this paper
• Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.

  1996cites this paper
• Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.

  1996cites this paper
• Neurochemical bases of locomotion and ethanol stimulant effects.

  1996cites this paper
• Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens.

  1996cites this paper
• MK‐801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens

  1996cites this paper
• 1S,3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, D,L-amphetamine-induced locomotion.

  1996cites this paper
• Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.

  1995cites this paper
• Dizocilpine enhances striatal tyrosine hydroxylase and aromatic L-amino acid decarboxylase activity.

  1995cites this paper
• Chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidance

  1995cites this paper
• Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice

  1995cites this paper
• Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex.

  1995cites this paper